In 1965 a preliminary study revealed the protective effect of oral chloramphenicol in adult male Wistar rats against hepatic carcinogenesis and cirrhosis induced by feeding 0.05%o N-2-fluorenyldiacetamide in a semisynthetic diet of Morris.! The chloramphenicol was fed at the level of 2 percent in the diet as the maximal tolerated dose according to the recommendation of Dr. A. C. Bratton, Jr., Director of Pharmacological Research at Parke, Davis, and Company who donated the chloramphenicol for both the preliminary and the present study.
diet and dose of chloramphenicol but no carcinogen. Following the twelfth week of carcinogen the animals received two weeks of semi-synthetic diet containing the appropriate dose of chloramphenicol but no carcinogen and then all of the rats were placed on Purina Laboratory Chow pellets ad libidum. The animals were kept alive for up to 68 weeks, after which they were killed and examined. All rats were autopsied and tissues were fixed in 10 percent formalin. Blocks of liver and lungs from each animal were embedded in paraffin, sectioned and stained with hematoxylin and eosin. In those animals with lesions in other organs, microscopic sections were similarly prepared for examination. Previous studies' had shown that a minimum of 25 weeks was necessary from the time the feeding of carcinogen was begun for the first hepatocellular carcinoma to develop. Consequently, four animals that died prior to 25 weeks were dropped from the experiment and are not included in the results shown in Table 2 . All of the animals tabulated lived for 45 weeks or more after the start of the experiment.
EXPERIMENT II
In an attempt to determine' to what extent N-2-fluorenyldiacetamide and/or'. its,, metabolic products were boun'd'into the protein of the liver cells, a separate short-term experiment was also performed. Forty-nine m'a,le-Wistar rats and e,ight fem,ales, weighing 200 to 250 grams each, were divided into four groups. Twenty males, were fed the basic semi-synthetic diet without carcinogen or chloramphenicol. Three were killed each week for the first four weeks and two each 'succeeding week through 8 weeks ; they served as baseline controls. Seventeen male rats were fed the diet containing ,carcinogen and were sacrificed at weekly intervals, generally two to three rats at a time 'for' four weelks and three more at eight weeks.' The eight female rats were treated similarly, with analysis of the liver protein from two animals'per period. The reinaining twelve male rats were fed 2 percent chloramphenicol in the carcinogen-containing diet and sacrificed periodically, generally in pairs up to four and a half weeks. Six rats were killed at 8 weeks following the start of the experiment. ' The amiiount of protein-bound carcinogen or its metabolic products in the, liver was determined by the method dtailed. below.
At the time of sacrifice of each animal the liver was removed, protein extracted and ultraviolet absorption at 554 m, was measured as an index of fluorenyl content according to the following procedure: The rats were anesthetized with ether. The abdomen of the rat was opened and the liver perfused with 35 ml;. of cold. 0.9% sodium chloride by injecting the portal vein after cutting the hepatic at,r,tgy and inferior vena ;,cava. The I OSTER, FIRMINGER, MORRISON liver was then removed, rinsed in cold 0.9% saline and blotted with absorbent paper, weighed, and 2 gm. aliquots were minced finely with scissors. The minced liver was placed in ten times its volume of saline and ground in a Duall homogenizer. The liver proteins were precipitated from the homogenized liver suspension by the addition of an equal volume of cold 10% trichloracetic acid (TCA). The liver proteins were sedimented by centrifuging in an International refrigerated centrifuge at 2,500 rpm for 15 minutes. The supernatent fluid was discarded and the precipitated proteins were washed again with 10% cold TCA. The TCA-precipitated liver proteins were then washed with cold 95% ethanol-chloroform (3 to 1 by volume), ethanol-diethyl ether (3 to 1 by volume) and diethyl ether. The granular, tissue-protein residue was placed in a preweighed evaporating dish, dried in a vacuum dessicator over calcium sulfate for 24 hours and weighed. Approximately 0.25 grams of powdered liver protein was obtained from each 2 gram aliquot of rat liver by this extraction procedure. Aliquots from this powdered tissue-protein extract were used for determination of fluorenyl content.
Fifty milligrams of dried rat liver protein from rats which had been fed the Morris diet containing N-2-fluorenyldiacetamide were placed in screw-capped test tubes containing 5 ml. of a mixture of two volumes of 95% ethanol and three volumes of concentrated hydrochloric acid. The acid-alcohol mixture containing the rat liver protein was placed in a 70°C. water bath and allowed to incubate for 1X2 hours. A reddishpurple color developed in the solvent from the rat liver protein samples that were taken from the rats which had been fed the semi-synthetic diet that contained N-2-fluorenyldiacetamide. The color developed slowly and reached a peak intensity after approximately 45 minutes of incubation. A spectral analysis was made using a Beckman DU spectrophotometer and the peak absorbancy of the liberated color occurred at 554 millimicrons, which corresponds to the color and absorption of known fluorenyl compounds studied in this laboratory.
RESULTS

EXPERIMENT I
All of the groups of animals lost weight initially but in 2 to 3 weeks they had regained their loss. Thereafter, there was a progressive gain in weight which began to level off at about 40 weeks and after about 55 weeks there was a gradual loss of weight ( Figure 1 ). The growth curves are quite similar among the four groups except terminally when the control group, which had the highest incidence of tumors, began to lose weight quite rapidly and averaged 48 grams per animal less than the most protected group on 2 percent chloramphenicol, 38 grams less than the group on 0.5 percent chloramphenicol and 22 grams less than the group on 0.1 percent chloramphenicol ( Table 2) .
The main findings at autopsy of the four groups of rats are shown in Table 2 .
In the control group receiving carcinogen but no chloramphenicol, 24 animals survived from 52 to 68 weeks. Of these, 18 lived 68 weeks, 16 plastic nodules. In this group, three animals developed pulmonary metastases from their hepatic carcinomas. All showed cystic changes in the liver, varying from minimal (10 animals) to moderate or extensively involved (14 animals). Five animals had neoplasms other than hepatocellular carcinomas in this group. They consisted of three bronchoalveolar cell tumors of the lung, one squamous cell carcinoma of the ceruminous gland of the ear and one bile duct adenoma. The liver weights varied from 21 to 106 grams and averaged 50.9 grams. Cirrhosis was not present in this or any of the subse- quent groups, but bile duct cysts were present in the liver of all of the animals in this group. Twenty-three animals survived from 45 to 68 weeks in the group that received carcinogen plus 2%o chloramphenicol. Sixteen lived 68 weeks and 12 of these had normal livers, two had small hyperplastic nodules and two developed hepatocellular carcinomas. Of the eight animals that expired prior to 68 weeks, two had hepatocellular carcinomas and one of these had pulmonary metastases. Minimal to moderate focal cystic changes were evident in the four animals with liver tumors. Eight neoplasms other than those in the liver were present: Four of these were squamous cell carcinomas from the ear, one was a large subcutaneous fibroma, two were transitional cell carcinomas from the urinary bladder, and one was a collision tumor consisting of both parenchymal adenocarcinoma of the kidney and transitional cell carcinoma of the renal pelvis. The livers varied from ten to thirtyseven grams in this group and averaged 22.1 grams.
In the group receiving 0.1%o chloramphenicol in the carcinogen-containing diet, 23 animals lived from 50-68 weeks. Thirteen of 20 rats that were sacrificed at 68 weeks and two of three animals expiring prior to 68 weeks had hepatocellular carcinomas. Two had developed pulmonary metastases from their tumors. In two animals, hyperplastic hepatic nodules were present. Hepatic cystic changes were present in all the animals with liver tumors and in seven without liver tumors. In seven the cystic changes were considered minimal, and in 15, moderate to marked. Two additional tumors, one bronchoalveolar cell tumor of the lung and one subcutaneous fibroma, were present. Liver weights ranged from 30 to 105 grams, and averaged 48.6 grams.
In the remaining group which received 0.5%b chloramphenicol with the carcinogen in the diet, 25 animals survived 46 to 68 weeks. Eleven of 18 sacrificed at 68 weeks had hepatocellular carcinomas, while four of seven that had expired previously had such tumors. Two animals had pulmonary metastases. Nine animals showed minimal cystic changes in the livers, and in ten the cystic changes were considered moderate to marked. No hepatic cystic changes were present in three of the rats with hepatocellular carcinomas. Only one additional tumor, a papillary transitional cell carcinoma of the urinary bladder was present in this group. Hepatic weights varied from 16 to 76 grams and averaged 35.3 grams.
The protective effect of chloramphenicol is represented graphically in Figure 2 .
Statistical analysis of these results using a modified X2 teste reveals highly significant influence of dosage on chloramphenicol inhibition with a p value of <<0.001. EXPERIMENT II Plots of the absorption of the acidified liver protein extracted from the four groups of rats in Experiment II are shown in Figure 3 ..
The decrease in-content of 554 m,L absorbing fluorenyl compound.in the liver of the relatively immune female rats, compared to male rats, is clearly evident. After one week, a statistical analysis applying the standard "t" test to these two groups revealed a significance with a p. << 0.001.
Male rats protected by the addition of 2%o chloramphenicol to.their diet showed some delay in obvious inhibition of binding but clearly diverged after three weeks from the male animals. fed carcinogen only. The significance of. decreased binding in the chloramphenicol group similarly has a p value of << 0.001. In a separate experiment not included here, in which rats were fed a diet containing. double .the dose of carcinogen (0.05%o) as was used in the long-term experiment reported previously, entirely comparable inhibition occurred in the chloramphenicol-treated rats.
DISCUSSION
Previous studies had shown the procarcinogenic action of androgenic and anabolic hormones in this model.' It was known from the work of the Millers" and otherse' that the carcinogen was bound to protein in the liver. Although these hormonal effects might increase the net metabolic quantity of active proximate carcinogen in the liver, it seemed more likely that the effects of the anabolic hormones was through increased protein synthesis in the liver which bound more carcinogen as an integral component when protein intake was partially restricted.
The role of the anabolic hormones as described by Kochakian°was considered to be the induction of more protein synthetic machinery in the liver In the present experiments, cirrhosis of the liver was not seen at the time of autopsy. Previous studiese using serial biopsies revealed that cirrhosis is reversible on the 0.025% dosage of carcinogen and only the cysts do not disappear. In the present experiment, the number and severity of the cystic changes in the liver was inversely proportional to the dosage of chloramphenicol. It had been found previously that a higher dose of carcinogen increases the degree and extent of cirrhosis more than it does the number of tumors and the extent of involvement in the liver. This fact, together with the shorter duration of the previous preliminary experiment, would seem to account for the presence of cirrhosis in the unprotected controls in that study.
The protective effect of chloramphenicol against the induction of hepatocellular carcinoma was confirmed by the present experiment and appears clearly dose related, but the mechanism is still unknown. The preliminary study of fluorenyl content of extracted liver protein does indicate decreased binding after three weeks when chloramphenicol is fed with the carcinogen. If binding in the liver is important in carcinogenesis and its binding is merely prevented by chloramphenicol, then the carcinogen should be released and excreted in the urine. This seems to be borne out by the increased number of tumors outside the liver in the protected animals (8/24) on 2 percent chloramphenicol compared to the threefold smaller number (8/72) in the combined unprotected group and the two less-protected groups. These differences are even more striking when one considers the increase only of the ear duct and urinary tract tumors, usual products of the somewhat more powerful but less specific N-2-fluorenylacetamide.& This is further substantiated by Weisburger and his associatesu who showed that the amount of the more carcinogenic N-hydroxy-N-2-fluorenylacetamide in the urine was increased in rats fed N-2-fluorenyldiacetamide and concurrent chloramphenicol. These findings exclude a block in formation of the proximate carcinogen or increased detoxication through inductive effects as the mechanism of protective action of chloramphenicol.
The slower rise of bound compound in chloramphenicol-fed animals (Figure 3 ) may reflect a short temporary inhibition of protein synthesis. The delayed fall of bound fluorenyl compound could suggest some inductive action may have to occur before the chloramphenicol is effective.
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Weisburger and his associatese' showed no reduction of incorporation of C1 labelled leucine into the protein pool of the liver in rats given chloramphenicol. Although this does not exclude possible inhibited production of a specific protein it would seem to point strongly to competition between chloramphenicol and the carcinogen as the mode of action of chloramphenicol. Of course the site of the competition, whether for enzyme, energy mechanics, t-RNA or direct binding sites in protein or nucleic acids, is a matter for further study. SUMMARY N-2-fluorenyldiacetamide-induced hepatic carcinogenesis in rats is effectively inhibited by feeding 2% chloramphenicol in the diet and is shown to be a dose-related phenomenon. Chloramphenicol effectively reduces binding of the carcinogen in the liver but does not prevent its metabolic formation or increase its detoxication. Instead it results in an increase in the types of tumors induced by the carcinogen in sites outside the liver. The findings suggest a competition between the carcinogen and chloramphenicol but the binding sites and the mechanism of their action requires further study.
